Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition

The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Sci...

Full description

Saved in:
Bibliographic Details
Published inCephalalgia Vol. 39; no. 6; pp. 687 - 710
Main Authors Diener, Hans-Christoph, Tassorelli, Cristina, Dodick, David W, Silberstein, Stephen D, Lipton, Richard B, Ashina, Messoud, Becker, Werner J, Ferrari, Michel D, Goadsby, Peter J, Pozo-Rosich, Patricia, Wang, Shuu-Jiun, Mandrekar, Jay
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.05.2019
Subjects
Original
acute treatment of migraine attacks in adults
controlled trials
Guidelines
Online AccessGet full text

Cover

Abstract The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.
AbstractList The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.
The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine . Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.
The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.
Author Lipton, Richard B
Goadsby, Peter J
Silberstein, Stephen D
Pozo-Rosich, Patricia
Mandrekar, Jay
Dodick, David W
Ashina, Messoud
Diener, Hans-Christoph
Tassorelli, Cristina
Becker, Werner J
Ferrari, Michel D
Wang, Shuu-Jiun
AuthorAffiliation 2 Headache Science Center, IRCCS Mondino Foundation, Pavia, Italy
4 Department of Neurology, Mayo Clinic, Phoenix, AZ, USA
8 Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
11 National Institute for Health Research Wellcome Trust King's Clinical Research Facility, King's College London, London, England
5 Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA
6 Montefiore Headache Center, Department of Neurology and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
14 Neurological Institute, Taipei Veterans General Hospital and Brain Research Center, National Yang-Ming University, Taipei, Taiwan
3 Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
7 Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark
13 Headache & Craniofacial Pain Unit, Neurology Depar
AuthorAffiliation_xml – name: 7 Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark
– name: 2 Headache Science Center, IRCCS Mondino Foundation, Pavia, Italy
– name: 6 Montefiore Headache Center, Department of Neurology and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
– name: 4 Department of Neurology, Mayo Clinic, Phoenix, AZ, USA
– name: 5 Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA
– name: 9 Hotchkiss Brain Institute, University of Calgary, Calgary, Canada
– name: 10 Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
– name: 12 Headache Research Group, Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Barcelona, Spain
– name: 11 National Institute for Health Research Wellcome Trust King's Clinical Research Facility, King's College London, London, England
– name: 14 Neurological Institute, Taipei Veterans General Hospital and Brain Research Center, National Yang-Ming University, Taipei, Taiwan
– name: 3 Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
– name: 15 Department of Health Sciences Research, Mayo Clinic Rochester, MN, USA
– name: 1 Department of Neurology, University Hospital Essen, Essen, Germany
– name: 8 Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
– name: 13 Headache & Craniofacial Pain Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
Author_xml – sequence: 1
  givenname: Hans-Christoph
  surname: Diener
  fullname: Diener, Hans-Christoph
  email: hans.diener@uni-duisburg-essen.de
– sequence: 2
  givenname: Cristina
  surname: Tassorelli
  fullname: Tassorelli, Cristina
– sequence: 3
  givenname: David W
  surname: Dodick
  fullname: Dodick, David W
– sequence: 4
  givenname: Stephen D
  surname: Silberstein
  fullname: Silberstein, Stephen D
– sequence: 5
  givenname: Richard B
  surname: Lipton
  fullname: Lipton, Richard B
– sequence: 6
  givenname: Messoud
  surname: Ashina
  fullname: Ashina, Messoud
– sequence: 7
  givenname: Werner J
  surname: Becker
  fullname: Becker, Werner J
– sequence: 8
  givenname: Michel D
  surname: Ferrari
  fullname: Ferrari, Michel D
– sequence: 9
  givenname: Peter J
  orcidid: 0000-0003-3260-5904
  surname: Goadsby
  fullname: Goadsby, Peter J
– sequence: 10
  givenname: Patricia
  surname: Pozo-Rosich
  fullname: Pozo-Rosich, Patricia
– sequence: 11
  givenname: Shuu-Jiun
  surname: Wang
  fullname: Wang, Shuu-Jiun
– sequence: 12
  givenname: Jay
  surname: Mandrekar
  fullname: Mandrekar, Jay
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30806518$$D View this record in MEDLINE/PubMed
BookMark eNp9Uctu1TAQtVARvS3sWSEv2aTYseM4LJBQRR9SJRbA2nLsyb0ujl1sB6lfwG_j9LYVVILVaGbOYzTnCB2EGACh15ScUNr37whjjJKW00G2chD9M7ShXMimrf0B2qzrZt0foqOcrwkhnSDiBTpkRBLRUblBv84XZ8G7ABnHCZcd4MtQIAVdXAza4wvQVps6_hKNg3KLp5iwiaGk6D1YXJLT_o6rzVKg9qDLDKGso9ltk67aWJeizfeMXcDaLr7k9_gsLqnsMFi3Or1Ez6eqA6_u6zH6dvbp6-lFc_X5_PL041VjOOOlsXJiAHZsLeXDpJnhAgyzU0dFJwYwdOAtB87Gse9HBq2dRi1NC3wUrR7q6Bh92OveLOMM1tRDk_bqJrlZp1sVtVN_b4LbqW38qURHKO-6KvD2XiDFHwvkomaXDXivA8Qlq5ZKQTmRUlTomz-9Hk0evl8BZA8wKeacYHqEUKLWgNXTgCtFPKEYV-6yqtc6_z9isydmvQV1XZ9f083_xv8GVqS5pg
CitedBy_id crossref_primary_10_1016_S0140_6736_20_32342_4
crossref_primary_10_1080_14737175_2022_2049758
crossref_primary_10_1177_15910199241307049
crossref_primary_10_1177_03331024231177636
crossref_primary_10_1177_03331024211048507
crossref_primary_10_1016_j_annemergmed_2024_11_004
crossref_primary_10_1111_head_13636
crossref_primary_10_1177_03331024251325526
crossref_primary_10_1177_2515816320958176
crossref_primary_10_1007_s40122_020_00185_1
crossref_primary_10_1111_head_14214
crossref_primary_10_3390_pharmaceutics12121180
crossref_primary_10_2196_40461
crossref_primary_10_1111_acem_14457
crossref_primary_10_1111_head_14295
crossref_primary_10_1177_03331024221093712
crossref_primary_10_1212_WNL_0000000000207544
crossref_primary_10_1177_0333102420906843
crossref_primary_10_3233_VES_210046
crossref_primary_10_1016_j_clinthera_2022_01_006
crossref_primary_10_1111_head_14292
crossref_primary_10_1080_14737175_2024_2365312
crossref_primary_10_1016_j_heliyon_2023_e16187
crossref_primary_10_1590_1806_9282_023d701
crossref_primary_10_1177_03331024211029939
crossref_primary_10_1111_acem_14879
crossref_primary_10_1016_j_pmn_2024_07_001
crossref_primary_10_3390_jcm13102768
crossref_primary_10_1111_head_14838
crossref_primary_10_1080_14737175_2021_1931127
crossref_primary_10_1007_s40122_020_00223_y
crossref_primary_10_1016_j_nrl_2019_09_010
crossref_primary_10_1093_pm_pnaa436
crossref_primary_10_1177_03331024231151419
crossref_primary_10_2147_JPR_S377289
crossref_primary_10_1111_head_14441
crossref_primary_10_1177_03331024241245658
crossref_primary_10_1097_WCO_0000000000001267
crossref_primary_10_1177_03331024211010413
crossref_primary_10_3389_fneur_2022_1032103
crossref_primary_10_1212_WNL_0000000000207672
crossref_primary_10_1055_s_0040_1705180
crossref_primary_10_1212_CON_0000000000000956
crossref_primary_10_1007_s40122_024_00703_5
crossref_primary_10_1177_03331024251318016
crossref_primary_10_1186_s12883_019_1420_5
crossref_primary_10_1007_s40122_023_00494_1
crossref_primary_10_1177_0333102420911461
crossref_primary_10_1177_03331024211028959
crossref_primary_10_29328_journal_jnnd_1001087
crossref_primary_10_1177_03331024231212900
crossref_primary_10_1111_head_14509
crossref_primary_10_1177_03331024221099035
crossref_primary_10_1093_asj_sjab416
crossref_primary_10_1080_00325481_2020_1767402
crossref_primary_10_1002_14651858_CD015367
crossref_primary_10_1111_head_14631
crossref_primary_10_1186_s12883_022_02714_1
crossref_primary_10_1111_head_14236
crossref_primary_10_1111_head_14753
crossref_primary_10_1016_j_ejpn_2021_02_008
crossref_primary_10_1097_AOG_0000000000005386
crossref_primary_10_1111_head_14077
crossref_primary_10_3389_fneur_2022_902020
crossref_primary_10_3390_jcm11030759
crossref_primary_10_1111_head_14350
crossref_primary_10_1186_s10194_022_01504_x
crossref_primary_10_1177_0333102420941839
crossref_primary_10_1177_03331024241258695
crossref_primary_10_3390_jcm11164686
crossref_primary_10_1186_s10194_025_01984_7
crossref_primary_10_1016_j_medcli_2024_02_006
crossref_primary_10_2217_pmt_2022_0082
crossref_primary_10_1001_jama_2021_7665
crossref_primary_10_3390_neurolint15010020
crossref_primary_10_3389_fneur_2023_1190062
crossref_primary_10_2174_0113816128266227231205114320
crossref_primary_10_1016_j_jen_2020_04_002
crossref_primary_10_1111_head_14739
crossref_primary_10_1186_s10194_022_01440_w
crossref_primary_10_1177_0333102419859313
crossref_primary_10_3389_fneur_2025_1511252
crossref_primary_10_1186_s10194_024_01915_y
crossref_primary_10_1177_0333102420956916
crossref_primary_10_1080_03007995_2023_2174746
crossref_primary_10_1111_head_13899
crossref_primary_10_1177_03331024221120266
crossref_primary_10_1177_0333102421989232
crossref_primary_10_48208_HeadacheMed_2023_5
crossref_primary_10_26442_00403660_2021_08_200920
crossref_primary_10_1111_jsr_13141
crossref_primary_10_1111_head_14069
crossref_primary_10_1177_0333102420970523
crossref_primary_10_1007_s40120_022_00369_1
crossref_primary_10_1212_WNL_0000000000201031
crossref_primary_10_4103_0028_3886_315995
crossref_primary_10_1111_head_14067
crossref_primary_10_1186_s10194_022_01519_4
crossref_primary_10_1007_s11916_022_01015_z
crossref_primary_10_1177_0333102420941827
crossref_primary_10_1186_s10194_021_01303_w
crossref_primary_10_1186_s10194_019_1051_7
crossref_primary_10_1007_s10072_021_05664_7
crossref_primary_10_24304_kjcp_2019_29_4_247
crossref_primary_10_1024_1661_8157_a003688
crossref_primary_10_1016_j_medcle_2024_02_011
crossref_primary_10_3389_fneur_2023_1273846
crossref_primary_10_4236_fns_2022_137050
crossref_primary_10_1016_j_msksp_2021_102386
crossref_primary_10_1016_j_scp_2024_101785
crossref_primary_10_3390_ph17081096
crossref_primary_10_1177_03331024221143773
crossref_primary_10_3390_cells12010143
crossref_primary_10_1016_j_clineuro_2021_106821
crossref_primary_10_1177_0333102421989247
crossref_primary_10_1186_s10194_020_01204_4
crossref_primary_10_3390_ph14090924
crossref_primary_10_1016_j_clineuro_2020_105853
crossref_primary_10_1038_s41598_022_09071_6
crossref_primary_10_1111_ner_13122
crossref_primary_10_3390_jcm11226876
crossref_primary_10_1111_ene_15103
crossref_primary_10_1186_s12883_020_01848_4
crossref_primary_10_1080_14656566_2020_1828347
crossref_primary_10_21518_ms2023_259
crossref_primary_10_2217_bem_2019_0024
crossref_primary_10_1007_s40120_022_00403_2
crossref_primary_10_1177_03331024231201576
crossref_primary_10_1177_25158163221114465
crossref_primary_10_3390_life14070910
crossref_primary_10_1186_s10194_019_1035_7
crossref_primary_10_1111_head_14488
crossref_primary_10_1177_03331024241252666
crossref_primary_10_1111_head_14124
crossref_primary_10_1111_jon_12918
crossref_primary_10_4103_singaporemedj_SMJ_2022_195
crossref_primary_10_1177_03331024211033829
crossref_primary_10_1017_cjn_2021_195
crossref_primary_10_1111_ane_13251
crossref_primary_10_1111_jocn_16368
crossref_primary_10_1007_s10072_021_05080_x
crossref_primary_10_3390_ijms24010657
crossref_primary_10_1080_14740338_2022_2078302
crossref_primary_10_1186_s10194_023_01662_6
crossref_primary_10_1177_03331024211006048
crossref_primary_10_1111_head_14308
crossref_primary_10_1111_head_14315
crossref_primary_10_1177_03331024211014625
crossref_primary_10_1097_AJP_0000000000001072
crossref_primary_10_1111_head_14430
crossref_primary_10_1111_head_14153
crossref_primary_10_14412_2074_2711_2023_2_126_133
crossref_primary_10_1371_journal_pone_0289729
crossref_primary_10_1093_biomtc_ujae023
crossref_primary_10_1136_bmj_2024_080107
crossref_primary_10_1177_03331024241234068
crossref_primary_10_1186_s12883_021_02220_w
crossref_primary_10_1002_jcph_1962
crossref_primary_10_1177_03331024211034509
crossref_primary_10_15829_1728_8800_2024_3782
crossref_primary_10_1111_head_14389
crossref_primary_10_1016_j_nrleng_2019_09_010
crossref_primary_10_3166_dea_2020_0125
crossref_primary_10_48208_HeadacheMed_2023_38
crossref_primary_10_1016_S0140_6736_20_30231_2
crossref_primary_10_1007_s40120_023_00576_4
crossref_primary_10_3389_fneur_2021_812678
crossref_primary_10_1177_03331024241298642
crossref_primary_10_2147_JPR_S453806
Cites_doi 10.1111/j.1526-4610.2005.05129.x
10.1016/S0140-6736(95)91554-0
10.1177/0333102411433042
10.1111/j.1468-1331.2009.02748.x
10.1111/j.1526-4610.2007.00805.x
10.1016/j.ijsu.2011.09.004
10.1177/0333102415584601
10.1517/13543784.7.4.633
10.1001/archneur.55.2.210
10.1176/appi.books.9780890425596
10.2165/11537990-000000000-00000
10.1111/j.1468-2982.2008.01806.x
10.1046/j.1526-4610.2003.03043.x
10.1111/j.1468-2982.2008.01546.x
10.1001/jama.1992.03480010072027
10.1111/j.1526-4610.2010.01771.x
10.1185/030079905X28926
10.1046/j.1468-2982.1984.0404253.x
10.2165/00003495-199958020-00016
10.1007/s10072-010-0273-x
10.1046/j.1468-2982.1985.0501005.x
10.1016/j.conctc.2016.05.003
10.1111/j.1468-2982.2004.00735.x
10.1111/j.1526-4610.2010.01627.x
10.1001/jama.2012.87802
10.1007/s10194-010-0243-y
10.1080/105294199277860
10.1046/j.1468-1331.2001.00260.x
10.1111/j.1526-4610.1995.hed3506330.x
10.1097/00019052-199706000-00012
10.1016/0895-4356(91)90147-2
10.1016/j.cct.2003.10.016
10.1007/s10194-005-0252-4
10.1177/0333102415575723
10.1046/j.1468-2982.1997.1705588.x
10.1136/bmj.292.6522.746
10.1111/j.1526-4610.2009.01412.x
10.1046/j.1468-2982.1996.1604239.x
10.1002/cpt1976202241
10.1177/0333102417738202
10.1111/j.1468-2982.2005.00981.x
10.1046/j.1468-2982.2002.00402.x
10.1111/j.1365-2796.1993.tb00732.x
10.1177/0333102410368441
10.1111/j.1600-0404.1990.tb00996.x
10.1046/j.1526-4610.2003.03044.x
10.1212/01.WNL.0000286940.29755.61
10.2165/00003495-199958040-00013
10.1177/0333102416653233
10.1212/WNL.55.10.1517
10.1002/sim.2716
10.7326/0003-4819-152-11-201006010-00232
10.1159/000067018
10.1177/0333102416657147
10.1016/S0149-2918(00)86731-4
10.1016/S0140-6736(01)06347-4
10.2147/IJWH.S63444
10.1177/03331024111430856
10.1111/j.1468-2982.2004.00817.x
10.1177/0333102413508661
10.1046/j.1468-2982.1999.019006552.x
10.1177/0333102499019S2302
10.1016/S0140-6736(01)06711-3
10.1002/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H
10.1093/ije/24.3.612
10.1093/brain/awu050
10.5414/CPP46421
10.1212/WNL.55.2.19A
10.1111/j.1468-2982.2000.00109.x
10.1177/0333102418758283
10.1056/NEJMoa030505
10.1016/S0895-4356(98)00107-3
10.2165/00003495-200060060-00003
10.1046/j.1468-2982.1995.1505423.x
10.1007/s10194-012-0422-0
10.1016/j.clinthera.2005.11.009
10.1136/bmj.c2697
10.1111/j.1468-2982.2007.01457.x
10.1186/s10194-017-0813-3
10.1046/j.1468-2982.1999.019004248.x
10.1016/j.euroneuro.2013.11.014
10.1046/j.1526-4610.1998.3810748.x
10.1111/j.1526-4610.2008.01285.x
10.1046/j.1468-2982.1990.1006305.x
10.1007/s00520-009-0720-5
10.1177/0333102413500727
10.1517/13543784.8.5.671
10.1046/j.1468-2982.2000.00069.x
10.1177/0333102411419682
10.1038/clpt.1991.1
10.1111/j.1600-0773.1990.tb00847.x
10.1212/WNL.55.5.629
10.1111/j.1468-2982.1992.00369.x
10.1046/j.1526-4610.2003.03188.x
10.1046/j.1468-2982.2000.00082.x
10.1046/j.1526-4610.1998.3803184.x
10.1212/WNL.51.3.773
10.1177/0333102410375512
10.1212/WNL.44.9.1587
10.2165/00003088-197803040-00004
10.1111/j.1468-2982.2005.00977.x
10.1046/j.1468-2982.2001.218256.x
10.1046/j.1468-2982.2000.00117.x
10.1046/j.1468-2982.1998.1808532.x
10.1111/j.1468-2982.2004.00741.x
10.1046/j.1468-2982.1997.1701037.x
10.1177/0333102409359091
10.1016/S0304-3959(01)00315-3
10.1002/pst.291
10.1111/j.1468-2982.2006.01097.x
10.1046/j.1526-4610.1998.3810737.x
10.1046/j.1468-2982.2002.00404.x
10.1159/000116757
10.1111/head.13165
10.1136/bmj.4.5939.265
10.1038/clpt.1991.143
10.1111/j.1468-1331.2004.00914.x
10.1046/j.1468-2982.1996.1604270.x
10.1212/WNL.55.6.754
10.1111/j.1526-4610.2008.01242.x
10.1007/s10072-006-0585-z
10.1177/0333102411417901
10.1186/s10194-016-0703-0
10.1177/0333102413500726
10.1212/WNL.43.7.1363
10.1111/j.1468-2982.2006.00991.x
10.1046/j.1468-2982.1991.1101001.x
10.1111/head.12550
10.1212/WNL.65.12_suppl_4.S50
10.1046/j.1526-4610.2002.0420s1003.x
ContentType Journal Article
Copyright International Headache Society 2019
International Headache Society 2019 2019 International Headache Society
Copyright_xml – notice: International Headache Society 2019
– notice: International Headache Society 2019 2019 International Headache Society
CorporateAuthor on behalf of the International Headache Society Clinical Trials Standing Committee
International Headache Society Clinical Trials Standing Committee
CorporateAuthor_xml – name: on behalf of the International Headache Society Clinical Trials Standing Committee
– name: International Headache Society Clinical Trials Standing Committee
DBID AFRWT
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1177/0333102419828967
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2982
EndPage 710
ExternalDocumentID PMC6501455
30806518
10_1177_0333102419828967
10.1177_0333102419828967
Genre Journal Article
GroupedDBID ---
-TM
.2F
.2G
.3N
.GJ
.Y3
01A
0R~
1OC
29B
31S
31T
31Y
31~
36B
4.4
53G
54M
5GY
5RE
5VS
6PF
8-1
AABMB
AABOD
AACKU
AADUE
AAGGD
AAHHS
AAJIQ
AAJOX
AAJPV
AANSI
AAPEO
AAQDB
AAQXH
AARDL
AARIX
AASGM
AAWTL
AAXOT
AAYTG
AAZBJ
ABAWC
ABAWP
ABCCA
ABCQN
ABDBF
ABDWY
ABEIX
ABFWQ
ABHKI
ABIVO
ABJIS
ABJNI
ABKRH
ABNCE
ABPGX
ABQKF
ABQXT
ABRHV
ABVFX
ABVVC
ABYTW
ACARO
ACCFJ
ACDSZ
ACDXX
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACNXM
ACOFE
ACROE
ACRPL
ACUHS
ACXQS
ADBBV
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADOGD
ADSTG
ADTBJ
ADUKL
ADYCS
ADZOD
ADZYD
ADZZY
AECVZ
AEEZP
AENEX
AEQDE
AEQLS
AERKM
AEUHG
AEWDL
AEXFG
AEXNY
AFBPY
AFCOW
AFEBI
AFEET
AFKBI
AFKRG
AFRWT
AFUIA
AFVCE
AFWMB
AFZJQ
AGNHF
AGQPQ
AHEFC
AIGRN
AIWBW
AJABX
AJAOE
AJBDE
AJEFB
AJMMQ
AJSCY
AJUZI
AJXGE
ALMA_UNASSIGNED_HOLDINGS
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
B8M
B8O
B93
BDDNI
BFHJK
BKSCU
BSEHC
BYIEH
CAG
CBRKF
CDWPY
CFDXU
CO8
COF
CORYS
CQQTX
CS3
CUTAK
DC-
DC.
DC0
DC6
DCZOG
DD-
DD0
DE-
DOPDO
DU5
D~Y
EAD
EAP
EAS
EBC
EBD
EBS
EBX
ECV
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
F5P
FEDTE
FZ0
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HVGLF
HZI
HZ~
IHE
J8X
K.F
K.J
LH4
LW6
N9A
O9-
OIG
OVD
P.B
P2P
Q1R
Q7K
Q7R
Q7X
Q82
Q~Q
ROL
S01
SASJQ
SAUOL
SCDPB
SCNPE
SFC
SV3
TEORI
TUS
W99
WYUIH
YFH
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
K97
M4V
NPM
7X8
5PM
ID FETCH-LOGICAL-c434t-d8f3eedb2d149fa3c46ec3df516569ec19424e43bb77b3e2dfba8c2e4b62a97b3
IEDL.DBID AFRWT
ISSN 0333-1024
1468-2982
IngestDate Thu Aug 21 13:54:32 EDT 2025
Fri Jul 11 15:57:32 EDT 2025
Thu Apr 03 07:07:11 EDT 2025
Tue Jul 01 05:22:04 EDT 2025
Thu Apr 24 23:06:40 EDT 2025
Tue Jun 17 22:45:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords acute treatment of migraine attacks in adults
controlled trials
Guidelines
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c434t-d8f3eedb2d149fa3c46ec3df516569ec19424e43bb77b3e2dfba8c2e4b62a97b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-1
ObjectType-Feature-3
content type line 23
These authors contributed equally to this work.
ORCID 0000-0003-3260-5904
OpenAccessLink https://journals.sagepub.com/doi/full/10.1177/0333102419828967?utm_source=summon&utm_medium=discovery-provider
PMID 30806518
PQID 2186140886
PQPubID 23479
PageCount 24
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6501455
proquest_miscellaneous_2186140886
pubmed_primary_30806518
crossref_primary_10_1177_0333102419828967
crossref_citationtrail_10_1177_0333102419828967
sage_journals_10_1177_0333102419828967
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-05-01
PublicationDateYYYYMMDD 2019-05-01
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
– name: Sage UK: London, England
PublicationTitle Cephalalgia
PublicationTitleAlternate Cephalalgia
PublicationYear 2019
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Goldstein, Roon, Offen 2001; 358
Thomsen, Dixon, Lassen 1996; 16
Cady, Martin, Geraud 2009; 49
Pascual, Vega, Diener 2000; 20
Tfelt-Hansen, Henry, Mulder 1995; 346
D'Amico, Moschiano, Usai 2006; 27
1991; 11
Loder, Goldstein, Biondi 2005; 25
Jakovljevic 2014; 24
Mitsikostas, Belesioti, Arvaniti 2017; 18
Tfelt-Hansen, De Vries, Saxena 2000; 60
Goldstein, Ryan, Jiang 1998; 38
Loder 2010; 30
Rasmussen, Jensen, Schroll 1991; 44
MacGregor 2014; 6
Dahlof, Rapoport, Sheftell 1999; 21
Lipton, Dodick, Adelman 2009; 29
Laska, Siegel, Sunshine 1991; 49
Olesen, Diener, Schoenen 2004; 11
Dowson, Bundy, Salt 2007; 47
Vetvik, Benth, MacGregor 2015; 35
Linde, Mellberg, Dahlof 2006; 26
Massiou, Tzourio, el Amrani 1997; 17
Diener, Dodick, Goadsby 2008; 28
Kramer, Matzura-Wolfe, Polis 1998; 51
Aicher, Peil, Peil 2012; 32
Schipper 1983; 128
Gardner, Altman 1986; 292
Tfelt-Hansen 1998; 18
Dmitrienko, Tamhane 2007; 6
Savi, Omboni, Lisotto 2011; 12
James, Bloch, Lee 1996; 15
Johnston, Rapoport 2010; 70
2018; 38
MacGregor, Chia, Vohrah 1990; 10
Tfelt-Hansen, Teall, Rodriguez 1998; 38
Ferrari, Roon, Lipton 2001; 358
Loder, Freitag, Adelman 2005; 21
Cleophas, Zwinderman 2008; 46
Schoenen 1997; 10
Hauge, Hougaard, Olesen 2010; 30
Lipton, McGinley, Shulman 2017; 57
Lipton, Hamelsky, Dayno 2002; 42
Silberstein 2000; 55
Volans 1974; 4
Goldstein, Offen, Moster 1999; 19
Ferrari 1999; 19
Olesen, Diener, Husstedt 2004; 350
Schulz, Altman, Moher 2011; 9
Russell, Rasmussen, Fenger 1996; 16
Schankin, Maniyar, Digre 2014; 137
Bang 2016; 3
Almas, Tepper, Landy 2014; 34
Ripamonti, Brunelli 2009; 17
Cooper, Beaver 1976; 20
Granella, Sances, Allais 2004; 24
Jensen, Tfelt-Hansen, Hansen 1995; 15
Brandes, Kudrow, Cady 2005; 25
Derry, Derry, Moore 2012
Cady, Gutterman, Saiers 1997; 17
Lainez, Evers, Kinge 2006; 26
Piaggio, Elbourne, Pocock 2012; 308
Tfelt-Hansen, Pascual, Ramadan 2012; 32
Diener, Peil, Aicher 2011; 31
Lipton, Stewart, Ryan 1998; 55
Autret, Valade, Debiais 2012; 13
Davies, Santanello, Lipton 2000; 20
Rodgers, Hustad, Cady 2011; 51
Russell, Rasmussen, Brennum 1992; 12
Cady, Dexter, Sargent 1993; 43
Dahlof, Lines 1999; 8
Ferrari, Goadsby, Roon 2002; 22
Goadsby, Zanchin, Geraud 2008; 28
Xu, Han, Wang 2016; 17
Lipton 2000; 55
Allen, Jiang, Malbecq 1999; 19
Dooley, Faulds 1999; 58
Pfaffenrath, Cunin, Sjonell 1998; 38
Abraha, Montedori 2010; 340
Voss, Lipton, Dodick 2016; 36
Lines, Vandormael, Malbecq 2001; 93
Dixon 1998; 6
Spencer, Gunasekara, Hills 1999; 58
Marcus, Bernstein, Sullivan 2010; 50
Dmitrienko, Wiens, Tamhane 2007; 26
Stewart, Lipton, Chee 2000; 55
Marcus, Goadsby, Dodick 2014; 34
Pageler, Diener, Pfaffenrath 2009; 49
Mathew, Hettiarachchi, Alderman 2003; 43
Mathew, Schoenen, Winner 2003; 43
Tullo, Allais, Ferrari 2010; 31
Evers, Afra, Frese 2009; 16
Viana, Sances, Linde 2017; 37
Lipton, Stewart 1998; 5
Thorlund, Mills, Wu 2014; 34
Tfelt-Hansen, Ryan 2000; 55
Lanteri-Minet, Mick, Allaf 2012; 32
Sheftell, Ryan, Pitman 2003; 43
Larsen, Christiansen, Andersen 1990; 81
Dahlof 1990; 1
Russell, Rasmussen, Thorvaldsen 1995; 24
Tfelt-Hansen, McCarroll, Lines 2002; 22
Kallela, Wessman, Havanka 2001; 8
Pilgrim 1991; 31
Hansen, Goadsby, Charles 2016; 36
Volans 1978; 3
Bousser, D'Allens, Richard 1993; 234
Schachtel, Thoden, Konerman 1991; 50
Rolan, Martin 1998; 7
Diener 2005; 45
Ho, Mannix, Fan 2008; 70
Ware, Kosinski, Gandek 1998; 51
Salonen, Ashford, Gibbs 1999; 105
Christie, Göbel, Mateos 2002; 49
Lipton, Bigal, Stewart 2005; 65
Tfelt-Hansen, Block, Dahlof 2000; 20
Tassorelli, Diener, Dodick 2018; 38
Laska, Siegel 2000; 20
1990; 67
Ferrari, Farkkila, Reuter 2010; 30
Santanello, Hartmaier, Epstein 1995; 35
ICH Harmonised Tripartite Guideline 1999; 18
Leonardi, Steiner, Scher 2005; 6
Klapper, Lucas, Rosjo 2004; 24
Becker 2015; 55
Tokola, Kangasniemi, Neuvonen 1984; 4
Johnson, Ratcliffe, Wilkinson 1985; 5
Stewart, Lipton, Celentano 1992; 267
Tfelt-Hansen 2010; 50
Bates, Ashford, Dawson 1994; 44
Bang, Ni, Davis 2004; 25
Schulz, Altman, Moher 2010; 152
Dahlof 2001; 21
Winner, Landy, Richardson 2005; 27
bibr5-0333102419828967
bibr26-0333102419828967
bibr69-0333102419828967
bibr118-0333102419828967
bibr85-0333102419828967
bibr42-0333102419828967
bibr44-0333102419828967
bibr18-0333102419828967
bibr101-0333102419828967
bibr144-0333102419828967
bibr50-0333102419828967
bibr87-0333102419828967
bibr36-0333102419828967
bibr128-0333102419828967
Lipton RB (bibr12-0333102419828967) 1998; 5
bibr79-0333102419828967
bibr136-0333102419828967
bibr93-0333102419828967
bibr28-0333102419828967
bibr103-0333102419828967
bibr75-0333102419828967
bibr108-0333102419828967
bibr62-0333102419828967
bibr111-0333102419828967
bibr11-0333102419828967
bibr124-0333102419828967
bibr24-0333102419828967
bibr91-0333102419828967
bibr83-0333102419828967
bibr16-0333102419828967
bibr70-0333102419828967
bibr142-0333102419828967
bibr89-0333102419828967
bibr116-0333102419828967
bibr134-0333102419828967
bibr126-0333102419828967
bibr121-0333102419828967
bibr52-0333102419828967
bibr3-0333102419828967
Derry CJ (bibr139-0333102419828967) 2012
bibr21-0333102419828967
bibr60-0333102419828967
Schipper H (bibr95-0333102419828967) 1983; 128
bibr113-0333102419828967
bibr34-0333102419828967
bibr73-0333102419828967
bibr81-0333102419828967
bibr48-0333102419828967
bibr13-0333102419828967
bibr64-0333102419828967
bibr22-0333102419828967
bibr39-0333102419828967
bibr72-0333102419828967
bibr131-0333102419828967
bibr14-0333102419828967
Lipton RB (bibr56-0333102419828967) 2000; 55
bibr1-0333102419828967
bibr140-0333102419828967
bibr80-0333102419828967
bibr107-0333102419828967
bibr123-0333102419828967
bibr132-0333102419828967
bibr146-0333102419828967
bibr7-0333102419828967
bibr92-0333102419828967
Dahlof C (bibr102-0333102419828967) 1990; 1
bibr67-0333102419828967
bibr138-0333102419828967
bibr53-0333102419828967
bibr33-0333102419828967
bibr120-0333102419828967
ICH Harmonised Tripartite Guideline (bibr29-0333102419828967) 1999; 18
bibr112-0333102419828967
bibr61-0333102419828967
bibr59-0333102419828967
bibr98-0333102419828967
bibr25-0333102419828967
bibr4-0333102419828967
bibr104-0333102419828967
bibr143-0333102419828967
bibr17-0333102419828967
bibr30-0333102419828967
bibr43-0333102419828967
bibr135-0333102419828967
bibr127-0333102419828967
bibr35-0333102419828967
bibr51-0333102419828967
bibr94-0333102419828967
bibr27-0333102419828967
bibr78-0333102419828967
bibr110-0333102419828967
bibr6-0333102419828967
bibr10-0333102419828967
bibr84-0333102419828967
bibr41-0333102419828967
bibr19-0333102419828967
bibr145-0333102419828967
Saxena PR (bibr63-0333102419828967) 2006
bibr45-0333102419828967
bibr88-0333102419828967
bibr37-0333102419828967
bibr137-0333102419828967
bibr96-0333102419828967
bibr76-0333102419828967
bibr129-0333102419828967
Salonen R (bibr20-0333102419828967) 1999; 105
bibr31-0333102419828967
bibr68-0333102419828967
bibr147-0333102419828967
bibr55-0333102419828967
bibr100-0333102419828967
Spilker B (bibr115-0333102419828967) 1991
bibr8-0333102419828967
bibr47-0333102419828967
bibr86-0333102419828967
bibr122-0333102419828967
bibr99-0333102419828967
bibr65-0333102419828967
bibr9-0333102419828967
bibr105-0333102419828967
bibr57-0333102419828967
bibr148-0333102419828967
bibr114-0333102419828967
bibr49-0333102419828967
bibr23-0333102419828967
bibr66-0333102419828967
Pocock S (bibr119-0333102419828967) 1984
bibr15-0333102419828967
bibr58-0333102419828967
bibr97-0333102419828967
bibr106-0333102419828967
bibr32-0333102419828967
bibr71-0333102419828967
bibr141-0333102419828967
bibr133-0333102419828967
bibr54-0333102419828967
bibr2-0333102419828967
bibr46-0333102419828967
bibr125-0333102419828967
bibr40-0333102419828967
bibr74-0333102419828967
bibr82-0333102419828967
bibr38-0333102419828967
bibr109-0333102419828967
bibr77-0333102419828967
bibr90-0333102419828967
bibr130-0333102419828967
bibr117-0333102419828967
References_xml – volume: 60
  start-page: 1259
  year: 2000
  end-page: 1287
  article-title: Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy
  publication-title: Drugs
– volume: 38
  start-page: 737
  year: 1998
  end-page: 747
  article-title: Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group
  publication-title: Headache
– volume: 21
  start-page: 791
  year: 2001
  end-page: 795
  article-title: Assessing patient preference in migraine treatment
  publication-title: Cephalalgia
– volume: 43
  start-page: 962
  year: 2003
  end-page: 974
  article-title: Tolerability and safety of eletriptan in the treatment of migraine: A comprehensive review
  publication-title: Headache
– volume: 30
  start-page: 1027
  year: 2010
  end-page: 1028
  article-title: Design considerations in migraine with aura trials: Learning from experience
  publication-title: Cephalalgia
– volume: 35
  start-page: 1261
  year: 2015
  end-page: 1268
  article-title: Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine
  publication-title: Cephalalgia
– volume: 17
  start-page: 1433
  year: 2009
  end-page: 1434
  article-title: Comparison between numerical rating scale and six-level verbal rating scale in cancer patients with pain: A preliminary report
  publication-title: Support Care Cancer
– volume: 32
  start-page: 226
  year: 2012
  end-page: 235
  article-title: Early dosing and efficacy of triptans in acute migraine treatment: The TEMPO study
  publication-title: Cephalalgia
– volume: 21
  start-page: 1823
  year: 1999
  end-page: 1836
  article-title: Rizatriptan in the treatment of migraine
  publication-title: Clin Ther
– year: 2012
  article-title: Sumatriptan (oral route of administration) for acute migraine attacks in adults
  publication-title: Cochrane Database Syst Rev
– volume: 12
  start-page: 369
  year: 1992
  end-page: 374
  article-title: Presentation of a new instrument: The diagnostic headache diary
  publication-title: Cephalalgia
– volume: 22
  start-page: 664
  year: 2002
  end-page: 666
  article-title: Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials
  publication-title: Cephalalgia
– volume: 16
  start-page: 239
  year: 1996
  end-page: 245
  article-title: Migraine without aura and migraine with aura are distinct clinical entities: A study of four hundred and eighty-four male and female migraineurs from the general population
  publication-title: Cephalalgia
– volume: 20
  start-page: 241
  year: 1976
  end-page: 250
  article-title: A model to evaluate mild analgesics in oral surgery outpatients
  publication-title: Clin Pharmacol Ther
– volume: 43
  start-page: 214
  year: 2003
  end-page: 222
  article-title: Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg
  publication-title: Headache
– volume: 346
  start-page: 923
  year: 1995
  end-page: 926
  article-title: The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
  publication-title: Lancet
– volume: 20
  start-page: 554
  year: 2000
  end-page: 560
  article-title: Determinants of patient satisfaction with migraine therapy
  publication-title: Cephalalgia
– volume: 42
  start-page: S3
  year: 2002
  end-page: S9
  article-title: What do patients with migraine want from acute migraine treatment?
  publication-title: Headache
– volume: 26
  start-page: 2465
  year: 2007
  end-page: 2478
  article-title: Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives
  publication-title: Stat Med
– volume: 358
  start-page: 1230
  year: 2001
  end-page: 1234
  article-title: Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: A randomised controlled trial
  publication-title: Lancet
– volume: 81
  start-page: 464
  year: 1990
  end-page: 467
  article-title: Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine
  publication-title: Acta Neurol Scand
– volume: 26
  start-page: 246
  year: 2006
  end-page: 256
  article-title: Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine
  publication-title: Cephalalgia
– volume: 49
  start-page: 20
  year: 2002
  end-page: 29
  article-title: Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine
  publication-title: Eur Neurol
– volume: 30
  start-page: 1170
  year: 2010
  end-page: 1178
  article-title: Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – a randomised proof-of-concept trial
  publication-title: Cephalalgia
– volume: 10
  start-page: 237
  year: 1997
  end-page: 243
  article-title: Acute migraine therapy: The newer drugs
  publication-title: Curr Opin Neurol
– volume: 25
  start-page: 735
  year: 2005
  end-page: 742
  article-title: Eletriptan in the early treatment of acute migraine: Influence of pain intensity and time of dosing
  publication-title: Cephalalgia
– volume: 55
  start-page: 1517
  year: 2000
  end-page: 1523
  article-title: Menstrual cycle and headache in a population sample of migraineurs
  publication-title: Neurology
– volume: 18
  start-page: 102
  year: 2017
  article-title: Patients' preferences for headache acute and preventive treatment
  publication-title: J Headache Pain
– volume: 58
  start-page: 699
  year: 1999
  end-page: 723
  article-title: Rizatriptan: A review of its efficacy in the management of migraine
  publication-title: Drugs
– volume: 55
  start-page: S3
  year: 2000
  end-page: S7
  article-title: Methodologic issues in acute migraine clinical trials
  publication-title: Neurology
– volume: 128
  start-page: 1367
  year: 1983
  end-page: 1370
  article-title: Why measure quality of life?
  publication-title: Can Med Assoc J
– volume: 49
  start-page: 1
  year: 1991
  end-page: 5
  article-title: Onset and duration: Measurement and analysis
  publication-title: Clin Pharmacol Ther
– volume: 13
  start-page: 191
  year: 2012
  end-page: 198
  article-title: Placebo and other psychological interactions in headache treatment
  publication-title: J Headache Pain
– volume: 32
  start-page: 6
  year: 2012
  end-page: 38
  article-title: Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
  publication-title: Cephalalgia
– volume: 17
  start-page: 37
  year: 1997
  end-page: 39
  article-title: Verbal scales in the acute treatment of migraine: Semantic categories and clinical relevance
  publication-title: Cephalalgia
– volume: 137
  start-page: 1419
  year: 2014
  end-page: 1428
  article-title: ‘Visual snow’ – a disorder distinct from persistent migraine aura
  publication-title: Brain
– volume: 31
  start-page: 295
  year: 1991
  end-page: 299
  article-title: Methodology of clinical trials of sumatriptan in migraine and cluster headache
  publication-title: Eur Neurol
– volume: 292
  start-page: 746
  year: 1986
  end-page: 750
  article-title: Confidence intervals rather than P values: Estimation rather than hypothesis testing
  publication-title: Br Med J (Clin Res Ed)
– volume: 24
  start-page: 612
  year: 1995
  end-page: 618
  article-title: Prevalence and sex-ratio of the subtypes of migraine
  publication-title: Int J Epidemiol
– volume: 19
  start-page: 248
  year: 1999
  end-page: 249
  article-title: Efficacy definitions for migraine studies
  publication-title: Cephalalgia
– volume: 9
  start-page: 672
  year: 2011
  end-page: 677
  article-title: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
  publication-title: Int J Surg
– volume: 34
  start-page: 258
  year: 2014
  end-page: 267
  article-title: Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis
  publication-title: Cephalalgia
– volume: 50
  start-page: 539
  year: 2010
  end-page: 550
  article-title: A prospective comparison between ICHD-II and probability menstrual migraine diagnostic criteria
  publication-title: Headache
– volume: 38
  start-page: 184
  year: 1998
  end-page: 190
  article-title: Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan
  publication-title: Headache
– volume: 70
  start-page: 1304
  year: 2008
  end-page: 1312
  article-title: Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
  publication-title: Neurology
– volume: 35
  start-page: 330
  year: 1995
  end-page: 337
  article-title: Validation of a new quality of life questionnaire for acute migraine headache
  publication-title: Headache
– volume: 19
  start-page: 552
  year: 1999
  end-page: 556
  article-title: Time-to-event analysis, or who gets better sooner? An emerging concept in headache study methodology
  publication-title: Cephalalgia
– volume: 17
  start-page: 113
  year: 2016
  article-title: Network meta-analysis of migraine disorder treatment by NSAIDs and triptans
  publication-title: J Headache Pain
– volume: 24
  start-page: 918
  year: 2004
  end-page: 924
  article-title: Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild
  publication-title: Cephalalgia
– volume: 358
  start-page: 1668
  year: 2001
  end-page: 1675
  article-title: Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: A meta-analysis of 53 trials
  publication-title: Lancet
– volume: 43
  start-page: 202
  year: 2003
  end-page: 213
  article-title: Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: A multicenter, double-blind, placebo-controlled study conducted in the United States
  publication-title: Headache
– volume: 70
  start-page: 1505
  year: 2010
  end-page: 1518
  article-title: Triptans for the management of migraine
  publication-title: Drugs
– volume: 17
  start-page: 588
  year: 1997
  end-page: 590
  article-title: Responsiveness of non-IHS migraine and tension-type headache to sumatriptan
  publication-title: Cephalalgia
– volume: 16
  start-page: 968
  year: 2009
  end-page: 981
  article-title: EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force
  publication-title: Eur J Neurol
– volume: 37
  start-page: 979
  year: 2017
  end-page: 989
  article-title: Clinical features of migraine aura: Results from a prospective diary-aided study
  publication-title: Cephalalgia
– volume: 26
  start-page: 712
  year: 2006
  end-page: 721
  article-title: The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan
  publication-title: Cephalalgia
– volume: 51
  start-page: 356
  year: 2011
  end-page: 368
  article-title: Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: Comparison to the current FDA requirement using the complete rizatriptan study database
  publication-title: Headache
– volume: 34
  start-page: 126
  year: 2014
  end-page: 135
  article-title: Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study
  publication-title: Cephalalgia
– volume: 28
  start-page: 383
  year: 2008
  end-page: 391
  article-title: Early vs. non-early intervention in acute migraine – ‘Act when Mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan
  publication-title: Cephalalgia
– volume: 93
  start-page: 185
  year: 2001
  end-page: 190
  article-title: A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients
  publication-title: Pain
– volume: 105
  start-page: 16
  year: 1999
  end-page: 24
  article-title: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: A double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group
  publication-title: Int J Clin Pract Suppl
– volume: 6
  start-page: 171
  year: 2007
  end-page: 180
  article-title: Gatekeeping procedures with clinical trial applications
  publication-title: Pharm Stat
– volume: 234
  start-page: 211
  year: 1993
  end-page: 216
  article-title: Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: A placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group
  publication-title: J Intern Med
– volume: 11
  start-page: 1
  year: 1991
  end-page: 12
  article-title: Guidelines for controlled trials of drugs in migraine
  publication-title: Cephalalgia
– volume: 21
  start-page: 381
  year: 2005
  end-page: 389
  article-title: Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: Results of a large double-blind placebo-controlled trial
  publication-title: Curr Med Res Opin
– volume: 16
  start-page: 270
  year: 1996
  end-page: 275
  article-title: 311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: A comparison of its absorption during a migraine attack and in a migraine-free period
  publication-title: Cephalalgia
– volume: 12
  start-page: 219
  year: 2011
  end-page: 226
  article-title: A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
  publication-title: J Headache Pain
– volume: 34
  start-page: 114
  year: 2014
  end-page: 125
  article-title: BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
  publication-title: Cephalalgia
– volume: 31
  start-page: S51
  year: 2010
  end-page: S54
  article-title: Frovatriptan versus zolmitriptan for the acute treatment of migraine: A double-blind, randomized, multicenter, Italian study
  publication-title: Neurol Sci
– volume: 55
  start-page: 778
  year: 2015
  end-page: 793
  article-title: Acute migraine treatment in adults
  publication-title: Headache
– volume: 58
  start-page: 347
  year: 1999
  end-page: 374
  article-title: Zolmitriptan: A review of its use in migraine
  publication-title: Drugs
– volume: 30
  start-page: 1041
  year: 2010
  end-page: 1048
  article-title: On the methodology of drug trials in migraine with aura
  publication-title: Cephalalgia
– volume: 44
  start-page: 1147
  year: 1991
  end-page: 1157
  article-title: Epidemiology of headache in a general population – a prevalence study
  publication-title: J Clin Epidemiol
– volume: 7
  start-page: 633
  year: 1998
  end-page: 652
  article-title: Zolmitriptan: A new acute treatment for migraine
  publication-title: Expert Opin Investig Drugs
– volume: 27
  start-page: S117
  year: 2006
  end-page: S122
  article-title: Treatment strategies in the acute therapy of migraine: Stratified care and early intervention
  publication-title: Neurol Sci
– volume: 55
  start-page: 754
  year: 2000
  end-page: 763
  article-title: Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommitee of the American Academy of Neurology
  publication-title: Neurology
– volume: 38
  start-page: 1
  year: 2018
  end-page: 211
  article-title: The International Classification of Headache Disorders, 3rd edition (ICHD-3)
  publication-title: Cephalalgia
– volume: 20
  start-page: 765
  year: 2000
  end-page: 786
  article-title: Guidelines for controlled trials of drugs in migraine: Second edition
  publication-title: Cephalalgia
– volume: 46
  start-page: 421
  year: 2008
  end-page: 427
  article-title: Random effects models in clinical research
  publication-title: Int J Clin Pharmacol Ther
– volume: 55
  start-page: 210
  year: 1998
  end-page: 217
  article-title: Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: Three double-blind, randomized, placebo-controlled trials
  publication-title: Arch Neurol
– volume: 31
  start-page: 1466
  year: 2011
  end-page: 1476
  article-title: The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: A post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study
  publication-title: Cephalalgia
– volume: 11
  start-page: 671
  year: 2004
  end-page: 677
  article-title: No effect of eletriptan administration during the aura phase of migraine
  publication-title: Eur J Neurol
– volume: 67
  start-page: 361
  year: 1990
  end-page: 372
  article-title: EEC note for guidance: Good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products
  publication-title: Pharmacol Toxicol
– volume: 350
  start-page: 1104
  year: 2004
  end-page: 1110
  article-title: Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine
  publication-title: N Engl J Med
– volume: 38
  start-page: 815
  year: 2018
  end-page: 832
  article-title: Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
  publication-title: Cephalalgia
– volume: 29
  start-page: 826
  year: 2009
  end-page: 836
  article-title: Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study
  publication-title: Cephalalgia
– volume: 44
  start-page: 1587
  year: 1994
  end-page: 1592
  article-title: Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group
  publication-title: Neurology
– volume: 24
  start-page: 333
  year: 2014
  end-page: 341
  article-title: The placebo-nocebo response: Controversies and challenges from clinical and research perspective
  publication-title: Eur Neuropsychopharmacol
– volume: 50
  start-page: 322
  year: 1991
  end-page: 329
  article-title: Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents
  publication-title: Clin Pharmacol Ther
– volume: 20
  start-page: 455
  year: 2000
  end-page: 461
  article-title: Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group
  publication-title: Cephalalgia
– volume: 27
  start-page: 1785
  year: 2005
  end-page: 1794
  article-title: Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: A pooled analysis of data from six clinical trials
  publication-title: Clin Ther
– volume: 19
  start-page: S2
  year: 1999
  end-page: S4
  article-title: How to assess and compare drugs in the management of migraine: Success rates in terms of response and recurrence
  publication-title: Cephalalgia
– volume: 25
  start-page: 143
  year: 2004
  end-page: 156
  article-title: Assessment of blinding in clinical trials
  publication-title: Control Clin Trials
– volume: 38
  start-page: 748
  year: 1998
  end-page: 755
  article-title: Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group
  publication-title: Headache
– volume: 18
  start-page: 532
  year: 1998
  end-page: 538
  article-title: Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
  publication-title: Cephalalgia
– volume: 6
  start-page: 65
  year: 1998
  end-page: 74
  article-title: The international conference on harmonization good clinical practice guideline
  publication-title: Qual Assur
– volume: 45
  start-page: 624
  year: 2005
  end-page: 631
  article-title: Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice
  publication-title: Headache
– volume: 8
  start-page: 671
  year: 1999
  end-page: 685
  article-title: Rizatriptan: A new 5-HT1B/1D receptor agonist for the treatment of migraine
  publication-title: Expert Opin Investig Drugs
– volume: 49
  start-page: 687
  year: 2009
  end-page: 696
  article-title: Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response
  publication-title: Headache
– volume: 4
  start-page: 253
  year: 1984
  end-page: 263
  article-title: Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks
  publication-title: Cephalalgia
– volume: 5
  start-page: 5
  year: 1985
  end-page: 10
  article-title: Naproxen sodium in the treatment of migraine
  publication-title: Cephalalgia
– volume: 340
  start-page: c2697
  year: 2010
  article-title: Modified intention to treat reporting in randomised controlled trials: Systematic review
  publication-title: BMJ
– volume: 3
  start-page: 313
  year: 1978
  end-page: 318
  article-title: Migraine and drug absorption
  publication-title: Clinical Pharmacokinetics
– volume: 3
  start-page: 117
  year: 2016
  end-page: 121
  article-title: Random guess and wishful thinking are the best blinding scenarios
  publication-title: Contemp Clin Trials Commun
– volume: 15
  start-page: 423
  year: 1995
  end-page: 429
  article-title: Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice
  publication-title: Cephalalgia
– volume: 28
  start-page: 35
  year: 2008
  end-page: 40
  article-title: Identification of negative predictors of pain-free response to triptans: Analysis of the eletriptan database
  publication-title: Cephalalgia
– volume: 152
  start-page: 726
  year: 2010
  end-page: 732
  article-title: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials
  publication-title: Ann Intern Med
– volume: 10
  start-page: 305
  year: 1990
  end-page: 310
  article-title: Migraine and menstruation: A pilot study
  publication-title: Cephalalgia
– volume: 24
  start-page: 707
  year: 2004
  end-page: 716
  article-title: Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres
  publication-title: Cephalalgia
– volume: 47
  start-page: 1144
  year: 2007
  end-page: 1151
  article-title: Patient preference for triptan formulations: A prospective study with zolmitriptan
  publication-title: Headache
– volume: 50
  start-page: 1198
  year: 2010
  end-page: 1200
  article-title: Early responses in randomized clinical trials of triptans in acute migraine treatment. Are they clinically relevantϿ A comment
  publication-title: Headache
– volume: 43
  start-page: 1363
  year: 1993
  end-page: 1368
  article-title: Efficacy of subcutaneous sumatriptan in repeated episodes of migraine
  publication-title: Neurology
– volume: 36
  start-page: 216
  year: 2016
  end-page: 224
  article-title: Variability of clinical features in attacks of migraine with aura
  publication-title: Cephalalgia
– volume: 51
  start-page: 773
  year: 1998
  end-page: 781
  article-title: A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group
  publication-title: Neurology
– volume: 22
  start-page: 633
  year: 2002
  end-page: 658
  article-title: Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials
  publication-title: Cephalalgia
– volume: 25
  start-page: 124
  year: 2005
  end-page: 131
  article-title: Placebo effects in oral triptan trials: The scientific and ethical rationale for continued use of placebo controls
  publication-title: Cephalalgia
– volume: 1
  start-page: 19
  year: 1990
  end-page: 25
  article-title: Minor Symptoms Evaluation (MSE) profile – a questionnaire for assessment of subjective CNS-related symptoms
  publication-title: Scand J Prim Health Care Suppl
– volume: 65
  start-page: S50
  year: 2005
  end-page: S58
  article-title: Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life
  publication-title: Neurology
– volume: 4
  start-page: 265
  year: 1974
  end-page: 268
  article-title: Absorption of effervescent aspirin during migraine
  publication-title: Br Med J
– volume: 36
  start-page: 887
  year: 2016
  end-page: 898
  article-title: A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
  publication-title: Cephalalgia
– volume: 20
  start-page: 724
  year: 2000
  end-page: 731
  article-title: Assessing the onset of relief of a treatment for migraine
  publication-title: Cephalalgia
– volume: 6
  start-page: 429
  year: 2005
  end-page: 440
  article-title: The global burden of migraine: Measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF)
  publication-title: J Headache Pain
– volume: 55
  start-page: S19
  year: 2000
  end-page: S24
  article-title: Oral therapy for migraine: Comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials
  publication-title: Neurology
– volume: 267
  start-page: 64
  year: 1992
  end-page: 69
  article-title: Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors
  publication-title: JAMA
– volume: 308
  start-page: 2594
  year: 2012
  end-page: 2604
  article-title: Reporting of noninferiority and equivalence randomized trials: Extension of the CONSORT 2010 statement
  publication-title: JAMA
– volume: 32
  start-page: 185
  year: 2012
  end-page: 197
  article-title: Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache
  publication-title: Cephalalgia
– volume: 49
  start-page: 646
  year: 2009
  end-page: 654
  article-title: Clinical relevance of efficacy endpoints in OTC trials based on the patients global efficacy assessment
  publication-title: Headache
– volume: 57
  start-page: 1570
  year: 2017
  end-page: 1582
  article-title: Faster improvement in migraine pain intensity and migraine-related disability at early time points with AVP-825 (sumatriptan nasal powder delivery system) versus oral sumatriptan: A comparative randomized clinical trial across multiple attacks from the COMPASS Study
  publication-title: Headache
– volume: 15
  start-page: 1421
  year: 1996
  end-page: 1434
  article-title: An index for assessing blindness in a multi-centre clinical trial: Disulfiram for alcohol cessation – a VA cooperative study
  publication-title: Stat Med
– volume: 8
  start-page: 441
  year: 2001
  end-page: 449
  article-title: Familial migraine with and without aura: Clinical characteristics and co-occurrence
  publication-title: Eur J Neurol
– volume: 18
  start-page: 1905
  year: 1999
  end-page: 1942
  article-title: Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group
  publication-title: Stat Med
– volume: 6
  start-page: 523
  year: 2014
  end-page: 535
  article-title: A review of frovatriptan for the treatment of menstrual migraine
  publication-title: Int J Womens Health
– volume: 5
  start-page: 2
  year: 1998
  end-page: 9
  article-title: Migraine headaches: Epidemiology and comorbidity
  publication-title: Clin Neurosci
– volume: 51
  start-page: 1159
  year: 1998
  end-page: 1165
  article-title: The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment
  publication-title: J Clin Epidemiol
– volume-title: Clinical trials. A practical approach
  year: 1984
  ident: bibr119-0333102419828967
– ident: bibr48-0333102419828967
  doi: 10.1111/j.1526-4610.2005.05129.x
– ident: bibr104-0333102419828967
  doi: 10.1016/S0140-6736(95)91554-0
– ident: bibr42-0333102419828967
  doi: 10.1177/0333102411433042
– ident: bibr148-0333102419828967
– ident: bibr98-0333102419828967
  doi: 10.1111/j.1468-1331.2009.02748.x
– ident: bibr106-0333102419828967
  doi: 10.1111/j.1526-4610.2007.00805.x
– ident: bibr125-0333102419828967
  doi: 10.1016/j.ijsu.2011.09.004
– ident: bibr134-0333102419828967
  doi: 10.1177/0333102415584601
– ident: bibr30-0333102419828967
  doi: 10.1517/13543784.7.4.633
– ident: bibr105-0333102419828967
  doi: 10.1001/archneur.55.2.210
– ident: bibr13-0333102419828967
  doi: 10.1176/appi.books.9780890425596
– ident: bibr135-0333102419828967
  doi: 10.2165/11537990-000000000-00000
– ident: bibr47-0333102419828967
  doi: 10.1111/j.1468-2982.2008.01806.x
– ident: bibr88-0333102419828967
  doi: 10.1046/j.1526-4610.2003.03043.x
– volume-title: Guide to clinical trials
  year: 1991
  ident: bibr115-0333102419828967
– ident: bibr43-0333102419828967
  doi: 10.1111/j.1468-2982.2008.01546.x
– ident: bibr11-0333102419828967
  doi: 10.1001/jama.1992.03480010072027
– ident: bibr68-0333102419828967
  doi: 10.1111/j.1526-4610.2010.01771.x
– ident: bibr18-0333102419828967
  doi: 10.1185/030079905X28926
– ident: bibr39-0333102419828967
  doi: 10.1046/j.1468-2982.1984.0404253.x
– ident: bibr33-0333102419828967
  doi: 10.2165/00003495-199958020-00016
– ident: bibr110-0333102419828967
  doi: 10.1007/s10072-010-0273-x
– ident: bibr51-0333102419828967
  doi: 10.1046/j.1468-2982.1985.0501005.x
– ident: bibr114-0333102419828967
  doi: 10.1016/j.conctc.2016.05.003
– ident: bibr136-0333102419828967
  doi: 10.1111/j.1468-2982.2004.00735.x
– ident: bibr147-0333102419828967
  doi: 10.1111/j.1526-4610.2010.01627.x
– ident: bibr122-0333102419828967
  doi: 10.1001/jama.2012.87802
– ident: bibr25-0333102419828967
– ident: bibr111-0333102419828967
  doi: 10.1007/s10194-010-0243-y
– ident: bibr117-0333102419828967
  doi: 10.1080/105294199277860
– ident: bibr7-0333102419828967
  doi: 10.1046/j.1468-1331.2001.00260.x
– ident: bibr101-0333102419828967
  doi: 10.1111/j.1526-4610.1995.hed3506330.x
– ident: bibr79-0333102419828967
  doi: 10.1097/00019052-199706000-00012
– ident: bibr81-0333102419828967
– ident: bibr9-0333102419828967
  doi: 10.1016/0895-4356(91)90147-2
– ident: bibr113-0333102419828967
  doi: 10.1016/j.cct.2003.10.016
– ident: bibr94-0333102419828967
  doi: 10.1007/s10194-005-0252-4
– ident: bibr145-0333102419828967
  doi: 10.1177/0333102415575723
– ident: bibr55-0333102419828967
  doi: 10.1046/j.1468-2982.1997.1705588.x
– ident: bibr123-0333102419828967
  doi: 10.1136/bmj.292.6522.746
– ident: bibr140-0333102419828967
  doi: 10.1111/j.1526-4610.2009.01412.x
– ident: bibr129-0333102419828967
  doi: 10.1046/j.1468-2982.1996.1604239.x
– ident: bibr73-0333102419828967
  doi: 10.1002/cpt1976202241
– ident: bibr6-0333102419828967
  doi: 10.1177/0333102417738202
– ident: bibr54-0333102419828967
– ident: bibr137-0333102419828967
  doi: 10.1111/j.1468-2982.2005.00981.x
– ident: bibr74-0333102419828967
  doi: 10.1046/j.1468-2982.2002.00402.x
– ident: bibr71-0333102419828967
– ident: bibr44-0333102419828967
  doi: 10.1111/j.1365-2796.1993.tb00732.x
– ident: bibr132-0333102419828967
  doi: 10.1177/0333102410368441
– ident: bibr52-0333102419828967
  doi: 10.1111/j.1600-0404.1990.tb00996.x
– ident: bibr100-0333102419828967
  doi: 10.1046/j.1526-4610.2003.03044.x
– ident: bibr24-0333102419828967
  doi: 10.1212/01.WNL.0000286940.29755.61
– ident: bibr32-0333102419828967
  doi: 10.2165/00003495-199958040-00013
– ident: bibr35-0333102419828967
  doi: 10.1177/0333102416653233
– ident: bibr143-0333102419828967
  doi: 10.1212/WNL.55.10.1517
– ident: bibr121-0333102419828967
  doi: 10.1002/sim.2716
– ident: bibr124-0333102419828967
  doi: 10.7326/0003-4819-152-11-201006010-00232
– start-page: 469
  volume-title: The headaches
  year: 2006
  ident: bibr63-0333102419828967
– ident: bibr108-0333102419828967
  doi: 10.1159/000067018
– ident: bibr133-0333102419828967
  doi: 10.1177/0333102416657147
– ident: bibr141-0333102419828967
  doi: 10.1016/S0149-2918(00)86731-4
– ident: bibr90-0333102419828967
  doi: 10.1016/S0140-6736(01)06347-4
– ident: bibr62-0333102419828967
  doi: 10.2147/IJWH.S63444
– year: 2012
  ident: bibr139-0333102419828967
  publication-title: Cochrane Database Syst Rev
– ident: bibr75-0333102419828967
  doi: 10.1177/03331024111430856
– ident: bibr16-0333102419828967
  doi: 10.1111/j.1468-2982.2004.00817.x
– ident: bibr118-0333102419828967
  doi: 10.1177/0333102413508661
– ident: bibr126-0333102419828967
  doi: 10.1046/j.1468-2982.1999.019006552.x
– ident: bibr60-0333102419828967
  doi: 10.1177/0333102499019S2302
– ident: bibr65-0333102419828967
  doi: 10.1016/S0140-6736(01)06711-3
– ident: bibr112-0333102419828967
  doi: 10.1002/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H
– ident: bibr10-0333102419828967
  doi: 10.1093/ije/24.3.612
– ident: bibr131-0333102419828967
  doi: 10.1093/brain/awu050
– ident: bibr50-0333102419828967
  doi: 10.5414/CPP46421
– ident: bibr84-0333102419828967
  doi: 10.1212/WNL.55.2.19A
– ident: bibr83-0333102419828967
  doi: 10.1111/j.1468-2982.2000.00109.x
– ident: bibr8-0333102419828967
  doi: 10.1177/0333102418758283
– ident: bibr21-0333102419828967
  doi: 10.1056/NEJMoa030505
– ident: bibr5-0333102419828967
– ident: bibr96-0333102419828967
  doi: 10.1016/S0895-4356(98)00107-3
– ident: bibr61-0333102419828967
  doi: 10.2165/00003495-200060060-00003
– ident: bibr15-0333102419828967
  doi: 10.1046/j.1468-2982.1995.1505423.x
– ident: bibr17-0333102419828967
  doi: 10.1007/s10194-012-0422-0
– ident: bibr138-0333102419828967
  doi: 10.1016/j.clinthera.2005.11.009
– ident: bibr26-0333102419828967
  doi: 10.1136/bmj.c2697
– ident: bibr28-0333102419828967
  doi: 10.1111/j.1468-2982.2007.01457.x
– ident: bibr36-0333102419828967
  doi: 10.1186/s10194-017-0813-3
– ident: bibr4-0333102419828967
– ident: bibr67-0333102419828967
  doi: 10.1046/j.1468-2982.1999.019004248.x
– ident: bibr14-0333102419828967
  doi: 10.1016/j.euroneuro.2013.11.014
– ident: bibr99-0333102419828967
  doi: 10.1046/j.1526-4610.1998.3810748.x
– ident: bibr85-0333102419828967
  doi: 10.1111/j.1526-4610.2008.01285.x
– ident: bibr144-0333102419828967
  doi: 10.1046/j.1468-2982.1990.1006305.x
– ident: bibr70-0333102419828967
  doi: 10.1007/s00520-009-0720-5
– ident: bibr23-0333102419828967
  doi: 10.1177/0333102413500727
– ident: bibr31-0333102419828967
  doi: 10.1517/13543784.8.5.671
– ident: bibr91-0333102419828967
  doi: 10.1046/j.1468-2982.2000.00069.x
– volume: 105
  start-page: 16
  year: 1999
  ident: bibr20-0333102419828967
  publication-title: Int J Clin Pract Suppl
– ident: bibr76-0333102419828967
  doi: 10.1177/0333102411419682
– ident: bibr82-0333102419828967
  doi: 10.1038/clpt.1991.1
– ident: bibr116-0333102419828967
  doi: 10.1111/j.1600-0773.1990.tb00847.x
– volume: 55
  start-page: S3
  year: 2000
  ident: bibr56-0333102419828967
  publication-title: Neurology
  doi: 10.1212/WNL.55.5.629
– ident: bibr103-0333102419828967
  doi: 10.1111/j.1468-2982.1992.00369.x
– ident: bibr87-0333102419828967
  doi: 10.1046/j.1526-4610.2003.03188.x
– ident: bibr57-0333102419828967
  doi: 10.1046/j.1468-2982.2000.00082.x
– ident: bibr34-0333102419828967
  doi: 10.1046/j.1526-4610.1998.3803184.x
– ident: bibr19-0333102419828967
  doi: 10.1212/WNL.51.3.773
– ident: bibr22-0333102419828967
  doi: 10.1177/0333102410375512
– ident: bibr128-0333102419828967
  doi: 10.1212/WNL.44.9.1587
– ident: bibr37-0333102419828967
  doi: 10.2165/00003088-197803040-00004
– ident: bibr78-0333102419828967
  doi: 10.1111/j.1468-2982.2005.00977.x
– ident: bibr109-0333102419828967
  doi: 10.1046/j.1468-2982.2001.218256.x
– ident: bibr2-0333102419828967
  doi: 10.1046/j.1468-2982.2000.00117.x
– ident: bibr86-0333102419828967
  doi: 10.1046/j.1468-2982.1998.1808532.x
– ident: bibr146-0333102419828967
  doi: 10.1111/j.1468-2982.2004.00741.x
– volume: 1
  start-page: 19
  year: 1990
  ident: bibr102-0333102419828967
  publication-title: Scand J Prim Health Care Suppl
– ident: bibr93-0333102419828967
– ident: bibr80-0333102419828967
  doi: 10.1046/j.1468-2982.1997.1701037.x
– ident: bibr130-0333102419828967
  doi: 10.1177/0333102409359091
– ident: bibr69-0333102419828967
  doi: 10.1016/S0304-3959(01)00315-3
– ident: bibr120-0333102419828967
  doi: 10.1002/pst.291
– volume: 5
  start-page: 2
  year: 1998
  ident: bibr12-0333102419828967
  publication-title: Clin Neurosci
– ident: bibr41-0333102419828967
  doi: 10.1111/j.1468-2982.2006.01097.x
– ident: bibr89-0333102419828967
  doi: 10.1046/j.1526-4610.1998.3810737.x
– ident: bibr66-0333102419828967
  doi: 10.1046/j.1468-2982.2002.00404.x
– ident: bibr59-0333102419828967
– ident: bibr45-0333102419828967
  doi: 10.1159/000116757
– ident: bibr49-0333102419828967
  doi: 10.1111/head.13165
– ident: bibr38-0333102419828967
  doi: 10.1136/bmj.4.5939.265
– ident: bibr72-0333102419828967
  doi: 10.1038/clpt.1991.143
– ident: bibr127-0333102419828967
  doi: 10.1111/j.1468-1331.2004.00914.x
– ident: bibr40-0333102419828967
  doi: 10.1046/j.1468-2982.1996.1604270.x
– ident: bibr97-0333102419828967
  doi: 10.1212/WNL.55.6.754
– ident: bibr77-0333102419828967
  doi: 10.1111/j.1526-4610.2008.01242.x
– ident: bibr142-0333102419828967
  doi: 10.1007/s10072-006-0585-z
– ident: bibr3-0333102419828967
  doi: 10.1177/0333102411417901
– ident: bibr64-0333102419828967
  doi: 10.1186/s10194-016-0703-0
– volume: 128
  start-page: 1367
  year: 1983
  ident: bibr95-0333102419828967
  publication-title: Can Med Assoc J
– ident: bibr46-0333102419828967
  doi: 10.1177/0333102413500726
– ident: bibr92-0333102419828967
  doi: 10.1212/WNL.43.7.1363
– volume: 18
  start-page: 1905
  year: 1999
  ident: bibr29-0333102419828967
  publication-title: Stat Med
– ident: bibr107-0333102419828967
  doi: 10.1111/j.1468-2982.2006.00991.x
– ident: bibr1-0333102419828967
  doi: 10.1046/j.1468-2982.1991.1101001.x
– ident: bibr27-0333102419828967
  doi: 10.1111/head.12550
– ident: bibr53-0333102419828967
  doi: 10.1212/WNL.65.12_suppl_4.S50
– ident: bibr58-0333102419828967
  doi: 10.1046/j.1526-4610.2002.0420s1003.x
SSID ssj0005606
Score 2.6189218
Snippet The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 687
SubjectTerms Original
Title Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
URI https://journals.sagepub.com/doi/full/10.1177/0333102419828967
https://www.ncbi.nlm.nih.gov/pubmed/30806518
https://www.proquest.com/docview/2186140886
https://pubmed.ncbi.nlm.nih.gov/PMC6501455
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fT9swED5BkSZeJtgGdAzkSdOkPWRtY8eJeZn4sayaxB4m0HiLbMeBSjSd1uSBv4B_m7vEKZRq014dxz75LvGdv893AB-iInJOaoGxCbeBCEURaAxtAxurgueJ1C6nu8PnP-T4Uny_iq7WoOzuwvgVnH8mWhVK1Pys6eum0-iBBxkHQ87RLcHNR1HAIOMvdTXN2tPurqgGtRA8XU8J2bbEh7wLuttt67ARxjIKe7BxnP78dfFICpHDFt3kxNgKxSOwuTLn8ka24p2ukiyfMMWazSvdgpfe62THrZlsw5orX8GLc4-rv4b7bzWluyIKPJsVDJ1CtnRUyMZoCpT6mXmWJ0Nfl3ma-63LWVP8o3lX27pybMFfp6bp5JoKUTimq4qu9LNJyZq8H_MjlqJo1Q1DSWimN3CZfr04HQe-RENgBRdVkCcFx13WhDlGWoXmVkhneV5ElNRHOTtSqH4nuDFxbLgL88LoxIZOGBlqhU070CtnpdsDlidGG1xbnqAXiV6FIsRPKYvjRFSWpg-Dbr0z6_OXUxmN22zUpSx_pqE-fFq88bvN3fGPvu87FWb4gRFqoks3q-cZFe3CKDRJZB92W5UuRuNDwqVJtnhJ2YsOlLx7-Uk5uWmSeMsG0I368JHMIuvs_q8Cvv3fjvuwiU6dakmZ76BX_andATpOlTlEaz85O0kPvdU_ALijFPU
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VrQRcEN8sn4MESBwCxXacBIlDBSxb2u0BbUVvqe04dKWSRWxWiF_Ab-FfMpM4KcsKxKXXxHZGHjt-k3l5A_AoLmPvtVEUm0gXKaHKyFBoG7kkK2WRauML_nd4sq_HB-r9YXy4AT-7f2HCDC6eMa2KLGpe1v3uZqUkKQmR0LmTcaygk8Cn3PXfv1G0tni184Zc-1iI0dvp63EUCgpETklVR0VaSjoTrCgoLiiNdEp7J4syZgmazDsK6IXySlqbJFZ6UZTWpE54ZbUwGV2icc_BporpxT-Aze3Rh4_TUz6J3moTo5LJXkKd5kTXbF49A9eA7To_8zeSWXPujS7DpQBYcbtdYVdgw1dX4fwkpOSvwY93S1bKYvY8zkskPIkrXxlxTKuIVaMxEESRYDIGhvyJL7CpG9L0NW5Ze-yp73zp8-wT17DwaOqa1QBwVmEjGbJ4iSMyrT5GsoSfdB0OzsQZN2BQzSt_C7BIrbE0tzIlAEqAJONkYZY5GifmijZDeN7Nd-6C9DlX4DjJX3Rq5394aAhP-x5fWtmPf7R92Lkwp73JCRdT-flykXO9Lwpg01QP4Wbr0n40ucUpbbYtWXF234B1v1fvVLPjRv9bN7ngeAhPeFnk3Zb5q4G3_7fhA7gwnk728r2d_d07cJGwYdZyO-_CoP669PcIf9X2flj5CEdnvdl-ATp2PQU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VrVRxQeV7SwEjARKHsIvtOAkSh4oStpRWCLWit-D4o12pZKtuVhW_gF_Df2QmcbYsKxCXXhPbGXns-E3m5Q3A09jHziktMTYRJpJc-khjaBuZJPPCpko7S_8O7-2r0aH8cBQfrcDP7l-YMIPTl0SrQoualzXt7jPrByHHOBgKgagEz56M4gWVBE7lrvt-gRHb9M3ONrr3Gef5u4O3oygUFYiMFLKObOoFngsltxgbeC2MVM4I62OSocmcwaCeSydFWSZJKRy3vtSp4U6WiusML-G412BVSowpe7C6lX_-cnDJKVHDNjkqiPDF5WVedMnmxXNwCdwuczR_I5o1Z1--DjcCaGVb7Sq7CSuuugVreyEtfxt-vJ-RWhYx6NnEM8SUbOFLIxvhSiLlaBZIogyhMgss-VNnWVM7pOmrzax2bE5_p0vfxsdUx8IxXdekCMDGFWtkQ6avWY6m1ScMLaEn3YHDK3HGXehVk8rdB2bTUpc4tyJFEIqgJKOEYZYZHCemqjZ9GHTzXZggf05VOE6LV53i-R8e6sOLeY-zVvrjH22fdC4scH9S0kVXbjKbFlTzC4PYNFV9uNe6dD6aGFJam2xLFpw9b0Da34t3qvFJowGumnxw3IfntCyKbtv81cCN_234GNY-befFx5393QdwHeFh1tI7N6FXn8_cQ4RgdfkoLHwGX696r_0CGdE-Hg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Guidelines+of+the+International+Headache+Society+for+controlled+trials+of+acute+treatment+of+migraine+attacks+in+adults%3A+Fourth+edition&rft.jtitle=Cephalalgia&rft.au=Diener%2C+Hans-Christoph&rft.au=Tassorelli%2C+Cristina&rft.au=Dodick%2C+David+W&rft.au=Silberstein%2C+Stephen+D&rft.date=2019-05-01&rft.pub=SAGE+Publications&rft.issn=0333-1024&rft.eissn=1468-2982&rft.volume=39&rft.issue=6&rft.spage=687&rft.epage=710&rft_id=info:doi/10.1177%2F0333102419828967&rft_id=info%3Apmid%2F30806518&rft.externalDocID=PMC6501455
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0333-1024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0333-1024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0333-1024&client=summon